Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases.
about
Phospholipase A(2) activation by poultry particulate matter is mediated through extracellular signal-regulated kinase in lung epithelial cells: regulation of interleukin-8 releaseImpact of CFTR DeltaF508 mutation on prostaglandin E2 production and type IIA phospholipase A2 expression by pulmonary epithelial cellsThe electrophile responsive proteome: integrating proteomics and lipidomics with cellular functionInvolvement of cAMP-response element binding protein-1 in arachidonic acid-induced vascular smooth muscle cell motilityCross-talk between oxysterols and glucocorticoids: differential regulation of secreted phopholipase A2 and impact on oligodendrocyte deathRole of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.Neutralization of Inflammation by Inhibiting In vitro and In vivo Secretory Phospholipase A2 by Ethanol Extract of Boerhaavia diffusa L.Biochemical and functional characterization of Parawixia bistriata spider venom with potential proteolytic and larvicidal activitiesSelective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inflammation.Structural effects of covalent inhibition of phospholipase A2 suggest allosteric coupling between membrane binding and catalytic sites.Functional analysis of two PLA2G2A variants associated with secretory phospholipase A2-IIA levels.Natural killer T cells: innate lymphocytes positioned as a bridge between acute and chronic inflammation?Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis.A novel polymorphism in secretory phospholipase A2-IID is associated with body weight loss in chronic obstructive pulmonary disease.Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease.Inhibition of secreted phospholipase A2 by neuron survival and anti-inflammatory peptide CHEC-9Unexpected Inflammatory Effects of Intravaginal Gels (Universal Placebo Gel and Nonoxynol-9) on the Upper Female Reproductive Tract: A Randomized Crossover Study.Differential expression of sPLA2 following spinal cord injury and a functional role for sPLA2-IIA in mediating oligodendrocyte deathAstrocytes regulate α-secretase-cleaved soluble amyloid precursor protein secretion in neuronal cells: Involvement of group IIA secretory phospholipase A2Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory painNeuroinflammatory pathways in binge alcohol-induced neuronal degeneration: oxidative stress cascade involving aquaporin, brain edema, and phospholipase A2 activation.Inhibition of interleukin-1beta-induced group IIA secretory phospholipase A2 expression by peroxisome proliferator-activated receptors (PPARs) in rat vascular smooth muscle cells: cooperation between PPARbeta and the proto-oncogene BCL-6Innate immunity and inflammation--two facets of the same anti-infectious reaction.Docosahexaenoic acid suppresses breast cancer cell metastasis by targeting matrix-metalloproteinases.Phospholipases A2 and inflammatory responses in the central nervous system.sPLA2-IIa is an inflammatory mediator when the ocular surface is compromisedAutoreactive natural killer T cells: promoting immune protection and immune tolerance through varied interactions with myeloid antigen-presenting cells.Role of cytosolic calcium-dependent phospholipase A2 in Alzheimer's disease pathogenesis.Strategies for triggered drug release from tumor targeted liposomes.Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.Proteome-wide prediction of targets for aspirin: new insight into the molecular mechanism of aspirin.Arachidonic acid induces an increase of β-1,4-galactosyltransferase I expression in MDA-MB-231 breast cancer cells.Molecular basis of the anti-inflammatory property exhibited by cyclo-pentano phenanthrenol isolated from Lippia nodiflora.Immunomodulatory drugs regulate HMGB1 release from activated human monocytes.Deletion of the G2A receptor fails to attenuate experimental autoimmune encephalomyelitis.Oxysterol and 9-cis-retinoic acid stimulate the group IIA secretory phospholipase A2 gene in rat smooth-muscle cells.Pseudomonas aeruginosa and sPLA2 IB stimulate ABCA1-mediated phospholipid efflux via ERK-activation of PPARalpha-RXR.Reciprocal modulation of C/EBP-α and C/EBP-β by IL-13 in activated microglia prevents neuronal death.Surfactant protein-A and phosphatidylglycerol suppress type IIA phospholipase A2 synthesis via nuclear factor-kappaB.A two-event in vitro model of acute chest syndrome: the role of secretory phospholipase A2 and neutrophils.
P2860
Q23920909-3A633EEA-6641-473E-9749-F0057829A732Q28181056-D2B8217C-CBFA-4FB0-9FFE-72F827E0D588Q28388959-93B680A1-9AC3-4C56-9C88-7738E5DC44C1Q28582121-975D9CFC-291F-44FF-93B4-56C089272B13Q30943736-814F3A5F-A6F3-42D5-BF2C-438BB7102087Q33565825-7F4DFFD9-0068-4D53-9F96-53C0D8FAFF1CQ33655690-D868EBAC-BA09-41E7-947D-ECBA04891D43Q33660928-8132785B-639B-48C7-A43B-77BFFD782705Q34014380-08F0D147-5751-4AC9-9F72-C2207620B669Q34180618-52A8A816-B88E-4FFF-8D9D-0B8DEA48E170Q34373883-54502AF7-2C65-41C4-B6EF-9EB567FEF628Q34388398-336E46FA-6271-4DB4-8EC2-0C321BB9C182Q34415813-C68002F2-AED1-4A53-9483-1C843C0D7E2FQ34432112-C97CA2E4-FF6D-4EF2-8758-C0A6981FD74AQ35094556-FDE17FA6-BAEB-4774-8231-784262C83A4BQ35110642-5AB7C081-45B6-4CAD-AA3A-86903177346CQ35692556-14E950C5-5F83-4171-AE8E-7E81182980C2Q35709144-FA6E3224-0151-4A92-A118-73EF4A8E16AAQ35798170-3781450E-8361-4E76-9A3A-7F11BCF0E2DDQ35847266-1C200B74-1F8F-4F00-95E1-A3D40402D7DAQ36233443-BA071ADE-4B89-4326-92D8-2058B1A08572Q36315919-FD63CD71-1D70-4650-B304-DCFB78D813C3Q37419474-2BC373E6-72C5-4C90-814E-141F43AAA579Q37580346-36061807-9DC4-4D19-926B-968DF9D5D568Q37621283-005C5F07-0603-470C-BE17-32E58F47926BQ37726033-1DFDFC05-C9D3-4891-BFE1-B89A51342785Q37750917-733B42C1-611C-400D-AC80-449A4094662CQ38014755-277A2BCE-71D0-414D-A877-252961E473ACQ38116638-9F1679FD-3673-40A1-A507-72AB2E0E27C4Q38682486-07E2CFC6-C004-49A8-B203-8A8D517D78D6Q39028044-8A9BB086-28CE-408F-81D1-44588F4F96A4Q39340351-36BF09B1-7A76-4124-BEC2-2A22ACBF3F8EQ39656068-F468F8B5-FEF6-462F-AB37-32B9E463841FQ41855892-0FF7987C-6ACC-4F48-BEBE-9C5CDAE13C67Q41880018-AA0AAE71-9CC2-4F71-9790-ED2C2B889918Q42069938-B3DAE580-39D0-4CB9-A7B2-F35A36843C80Q42776433-C814D72A-9DCA-42C2-B7A0-A81C4FFA50F5Q43965891-13D46B32-D9E4-4A38-BA51-CCE6232841CBQ46504389-5FB69C4E-8A75-4181-83D6-6791B5DEDCB1Q50528719-075A6B17-E060-469F-8EB2-F4122199C04E
P2860
Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Mammalian secreted phospholipa ...... ance in inflammatory diseases.
@ast
Mammalian secreted phospholipa ...... ance in inflammatory diseases.
@en
Mammalian secreted phospholipa ...... ance in inflammatory diseases.
@nl
type
label
Mammalian secreted phospholipa ...... ance in inflammatory diseases.
@ast
Mammalian secreted phospholipa ...... ance in inflammatory diseases.
@en
Mammalian secreted phospholipa ...... ance in inflammatory diseases.
@nl
prefLabel
Mammalian secreted phospholipa ...... ance in inflammatory diseases.
@ast
Mammalian secreted phospholipa ...... ance in inflammatory diseases.
@en
Mammalian secreted phospholipa ...... ance in inflammatory diseases.
@nl
P356
P1476
Mammalian secreted phospholipa ...... ance in inflammatory diseases.
@en
P2093
M Alaoui-El-Azher
P304
P356
10.2174/1566524013363258
P577
2001-12-01T00:00:00Z